Research Article
Factors Influencing Blood Concentration of Voriconazole and Therapeutic Drug Monitoring in Patients with Child–Pugh Class C Cirrhosis
Figure 3
Distribution of voriconazole trough plasma concentrations (Cmin) in normal metabolizers (NMs), intermediate metabolizers (IMs), and poor metabolizers (PMs) of the CYP2C19 enzyme.
| (a) |
| (b) |